[Tsinghua-NC] 新年快乐！ 开年大戏，UCAHP北美创业大赛，1/10 周六

报名: startup21.eventbrite.com   五折Discount Code: U5ALM50 (limited), 名额有限，欲报从速；

 3人5人团购更优惠，免费早午餐，三次抽奖机会 (ipad等)和独具慧眼大奖(观众选中最佳团队者)

第五届预告：http://www.tudou.com/programs/view/sY2y9cfhKZ0/

往届视频：http://www.tudou.com/home/_459082077

详情：http://startup21.org/  

第五届UCAHP北美创业大赛于2014年8月10日在美国硅谷启动，经过三轮评选，决赛于2015年1

月10日在圣塔克拉拉会议中心盛大举行。2000名专业人士，场面壮观，风投、园区、创业者，风

云际会，实为华人创业的开年盛事。

大赛项目涵盖云计算、移动互联网、物联网、生物医药及器械、新材料、新能源、集成电路和系

统、光电和装备, 智能家电，社交，金融等。

 50创业团队，两轮Pitch，50个评委，百名中美投资人。团队和导师PK，最具人气环节，

投资人/创业者如何互选？Dumb Money/Smart Money分辨？真天使/好VC？多个风投现场

投资抢案子 (有钱就可以任性?)

 Keynote Speakers

o 中国驻旧金山总领馆毕刚副总领事

o David Karandish,  Answers.com, 30岁的10亿美金公司创始人

o Frankin奖得主张首晟院士 (美国艺术与科学院、中国科学院、Stanford)

o 阿里巴巴数据科学研究院副院长金榕博士

 导师名单

陈大同、贾石琏、李泉生、李湘、潘建岳、薛军、余军、云维杰、武平、张震、张希盛

 百名中美投资人

清华企业家协会，北大企业家俱乐部，若水合投，丹华资本，TEEC天使、未名天使、丰元

创投、武岳峰、达泰资本、盈富泰克、华山资本、清芯华创、高榕资本、北极光、金沙江

、Beyondsoft Venture、西湖资本等

 潮流公司未来论坛，Google/Yahoo/FB/LinkedIn/Mozilla/ServiceMax/TiKL华裔最高职位的

高管论坛

o Gong Li, President, Mozilla

o Jinlin Wang (王金林), CTO, Answers 

o Richard Liu (刘友忠), Director, Google

o Xuhui Shao (邵旭辉), VP, Yahoo

o David Wei (魏晓亮), Director, Facebook

o Vivian Wong, SVP, ServiceMax

o Simon Zhang  (张溪梦), Sr. Director, LinkedIn

o Nan Zhong  (衷南), founder/CTO, TiKL

 Young Entrepreneur Award, 青少年创业奖(高中生或以下)；青少年论坛Panelists

o Eric Chen(Last year's winner, Harvard Freshman, Google/Siemens/Intel grand prize 

winner)

o Martin Hu(Co-founder Predictive Edge while studying in Stanford, sold to Dropbox)

 同天同场举行分赛敦煌网电商创业大赛，南京321创业大赛

o 跨境电商/国货销美的创业机会(头奖5000刀)，成为敦煌网合作伙伴，免除后台和

物流烦扰。继续接受电商创业项目报名 (startup21@ucahp.org) 。1/10现场比赛，

电商大拿评委。

o 南京321创业大赛，如何成为6000多申报者中的700名技术评审通过者？上届美西

大赛获得者如何获得321A类200万？1/10现场评比美西优胜团队，报名从速

（bit.ly/2015NJ321）。

 十个城市与园区

苏州市、南京市、杭州经济技术开发区、青岛高新技术开发区、张江高科技园区、中关村

园区、上海嘉定区、潍坊市/潍坊硅谷高科技孵化器、太原高新技术产业开发区，华夏幸

福硅谷孵化器。现场对接，午间推介专场

 Exhibition Booth 

$150 per table, 观众票选第一名将获得1000美金

 Startup21决赛50项目名单

多能干细胞定向造血干细胞分化试剂盒的开发 

"out" social network 

3D Stereo Camera System 

Advanced security volunrability inspector 

智能手机照片to短视频APP 

Cash Management Solution 

CMOS SOI smartphone RF Frontend 

Healther Anaystics and doctors finding 

IC Warpage measurement system 

iDx: a handheld device for rapid disease diagnosis 

livestream "last-mile"location updates in meet-ups 

Microfluidics Technology for Single Cell Sorting and 

Dispensing 

Mobile Strategy game - Ruin Wars 

Neck wearable camera 

OCR境外餐饮移动平台 

paperless in reimbursement 

PneumoGel Sealant: Lung Biopsy Safety System 

Scalable and Fine-grained Location Tracking System and Service 

for Enterprise 

smart device/app/call center System connecting elder/family 

Smart HUD System 

Tableau for unstructured data 

Visual Storytelling 平台及应用 

Wall of Power 

Wearable Identity and Access management 

车联网安全智能硬件 

服饰信息搜寻与虚拟试衣(Cit&Fit) 

干细胞治疗多发性硬化及多种自身免疫系统疾病 

华尔街情报网 

基于煤电厂的绿藻生物燃油与高价值生物制品生产系统 

基于智能手机能量传感器和新型可穿戴式生物传感器研发及产业化 

集镇痛、血管显影及止血功能的趣味注射胶贴 

清洁汽油替代燃料生物异丁醇 

全流程跨地区互联网医院 

说说日历-能听懂说话的日历 

土壤重金属污染的微生物修复 

微传感结构安全监测 

无线LED灯控及音乐同步 

吸入式胰岛素 

新一代视音频互动云平台及网络应用 

新一代云计算身份安全平台 

整合POS和社交的智能餐厅多级云平台 

智能轮椅 

智能图形识别图形设计云平台 

0辐射无线充电 

滑雪睛灵 

基于iBeacon的会员管理和品牌营销系统 

移动应用的百变智能化及平台 

online used car auction 

智能同伴 

Real time predictive Parking system with data analytics 

面向北美市场的眼镜电子商务及移动APP项目 

PneumoGel Sealant: Lung Biopsy Safety System 

宠物用品O2O电商 

Save on purchases by stacking all kinds of rewards. 

"逆向热响应" 固有安全锂电池胶体电解质 

智能家庭网络与感测芯片 

反向O2O再造服装实体店 

背触控技术 

 评委名单

Connie Sheng、石宏、薛宏、李峻、Chen Xuan， Sandy sharma，赵铁民、刘勇、金学成、

王金林、Richard Liu、邵旭辉、张仁辉、魏小亮、吴军、吾立峰、赵福勇、李湘、Linda 

Zhou、谷安佳、张首晟、Rachel Wan、李强、张于庆、李军、Michael Zhao、宋宇海、陈

晓伟、杨岩、韩鑫、成朋、李泉生、叶滨、孙中平、张鸿飞、陆俊秀、葛培健、黄海燕、

吴瑕、肖焰恒、虞向群、刘金波、谈锋、姜忠孝、王践识、马文祥、王艳春、王金林、金

榕、夏淳、何新平、武平、张震、贾石琏、李泉生、潘建岳、薛军、余军、云维杰、孔德

海、张希盛

美中高层次人才交流协会(UCAHP) ---桥接中美、孵化创新、投资创业---

Web: www.ucahp.org

Subscribe: go to http://groups.google.com/group/chinatalentpub/subscribe?hl=en

Contact Group Owner Email: ChinaTalentOffice@gmail.com   Phone: (408) 384-9688

__._,_.___

---

Posted by: thaa_nc@yahoo.com

---

    ------
    Tsinghua Alumni Association of Northern California
    Group policy: http://www.tsinghua-nc.org/about/email

Visit Your Group

• Privacy • Unsubscribe • Terms of Use

[Tsinghua-NC] Fwd: Please help promote 1/8 MJ Forum: Breakthrough Treatment Options for Diverse Types of Cancer Patients with Immune-oncology Approaches [2 Attachments]

---------- Forwarded message ----------
From: Helen Hsieh <helenhsieh0227@gmail.com>
Date: Tue, Jan 6, 2015 at 12:27 AM
Subject: Please help promote 1/8 MJ Forum: Breakthrough Treatment Options for Diverse Types of Cancer Patients with Immune-oncology Approaches
To: Kai Yang <popov.kai@gmail.com>

Dear Kai, 

Please help promote this event. The flyer in Chinese and English can both be found in the attachment. Thanks.

Best regards,

Helen

-----

Monte Jade Forum (Jan. 2015): Breakthrough Treatment Options for Diverse Types of Cancer Patients with Immune-oncology Approaches

Event Date: Thursday, January 8, 2015
Time: 6:30PM-9:00PM
Location: ITRI Int'l, 2870 Zanker Rd., Suite #140, San Jose, CA 95134
Moderator and Panelists:
Roxanne Duan, Director, External Collaborations, MedImmune, LLC. (Moderator)
Cheng Liu, CEO of Eureka Therapeutics, Inc.
Sonny Hsiao, CEO of Adheren, Inc.
John C. Lin, VP, Experimental Medicine & Cancer Immunotherapy, Pfizer, Inc.
Registration: Please register in advance. Click here.
Member & Student $10, Non-Member$20, extra $5 for site registration
Contact Info: service@montejade.org
Light refreshments and drink will be provided. 

 

This panel discussion will focus on the recent breakthrough treatment options, namely "immune-oncology" approaches, for a variety of cancer. The moderator will give a general introduction of the immmuno-oncology approaches and a few examples of amazingly cancer patient responses, as high as response rate in the 90% range, to immune-oncology therapies. A panel of internationally renowned researchers, clinicians and entrepreneurs will be available to discuss current clinical trials, potential issues, and investment opportunities in immune-oncology therapies for different cancer, as well as hosting a Question & Answer session at the end.

 

Speakers and Moderator Bio:

Roxanne Duan

Dr. Roxanne Duan joined MedImmune in 2012 as Director of External Collaborations. She spearheads external collaborations with academia, government and non-profit organizations and champions the formation of the Brazilian Science without Borders postdoc program at MedI. Before joining MedImmune, Roxanne was Director of External Discovery at GSK China with the goal to bring in assets from academic laboratories. Prior to GSK China, she was VP for R&D at Adlyfe, Inc., working on diagnostic methods and therapeutics for Alzheimer's disease. Before Adlyfe, Roxanne was VP of R&D at Functional Genetics, Inc. where she led team to the invention and development of broad-spectrum antiviral therapeutics against human targets. Prior to Functional Genetics, Roxanne was a Project Leader at Human Genome Sciences, Inc. She discovered protein drugs from gene sequences and led teams to develop them, resulting in the filing of three protein drug INDs. Roxanne has a Ph.D. degree in Pharmaceutical Chemistry from University of California, San Francisco, did postdoctoral fellowships in tumor suppressor genes at the NIH and in growth factor signalling at HHMI, had extensive experiences in protein and antibody drug discovery. She also took on roles in the Advisory Board of Women in Bio and the head of Chinese Biopharmaceutical Association. Roxanne holds more than 30 original publications, 82 published patents and 26 allowed patents.

 

Cheng Liu

Dr. Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health.. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.

 

John C. Lin

Dr. John C. Lin is currently Vice President, Experimental Medicine & Cancer Immunotherapy at Pfizer Inc. John has worked at a biotech startup Rinat since 2002, through its acquisition by Pfizer in 2006. Before that he was a postdoctoral fellow at Genentech Inc. from 1999-2001. He obtained a Ph.D. in Biological and Biomedical Sciences from Harvard Medical School in 1998, and his M.D. from the College of Medicine of National Taiwan University in 1992.

 

John is dedicated to developing novel immunotherapeutic agents to address the key mechanisms of serious human diseases. He investigated beta amyloid peptide's impact on the age-related macular degeneration and Alzheimer's disease. He conceived of the original idea of passive immunotherapy targeting PCSK9 for LDL lowering in 2006. His team also unveiled the critical roles of the cytokine interleukin 7 in the pathogenesis of multiple sclerosis and type 1 diabetes.

 

In 2013 his research responsibility has expanded into leading the overall strategy of cancer immunology in Pfizer, including checkpoint inhibitors, co-stimulators and CAR T cell therapy. For instance, he is responsible for establishing Pfizer's collaboration with MD Anderson Cancer Center's Immunotherapy Platform (Jan 2014), collaboration with Cellectis on CAR-T technology (Jun 2014) and collaboration with Kyowa H. Kirin on 4-1BB / CCR4 combination therapy in solid tumors (Sep 2014).

 

Sonny Hsiao

Dr. Sonny Hsiao is CEO of Adheren, Inc. He manages R&D projects in the development of immunotherapies based on cell-conjugated antibodies for cancer. He also leads the development of a novel technology platform that uses chemical methods to conjugate any therapeutic moiety onto solid surfaces such as silicon, glass or living cells. As a young PI, Sonny is currently managing a NCI-IMAT R33 grant and several collaborations with academic laboratories, including David Schaffer lab at UC Berkeley, Zev Gartner lab at UCSF, Stuart Martin lab at U of Maryland, and Monica Hinds lab at OHSU. Sonny obtained his Ph.D. degree in Chemistry and Chembio from UC Berkeley.

__._,_.___

View attachments on the web

---

Posted by: Kai Yang <Popov.kai@gmail.com>

---

    ------
    Tsinghua Alumni Association of Northern California
    Group policy: http://www.tsinghua-nc.org/about/email

Visit Your Group

• Privacy • Unsubscribe • Terms of Use